Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptor
Mario Gonzalez-Gronow, Steven Kaczowka, Govind Gawdi, Salvatore V. Pizz
[Frontiers in Bioscience 13, 1610-1618, January 1, 2008]

The role of CD26/dipeptidyl peptidase IV in cancer
Pamela A. Havre, Masako Abe1, Yasuyo Urasaki, Kei Ohnuma, Chikao Morimoto, Nam H. Dang
[Frontiers in Bioscience 13, 1634-1645, January 1, 2008]

Dipeptidyl peptidase iv inhibitors and diabetes therapy
Christopher H.S. McIntosh
[Frontiers in Bioscience 13, 1753-1773, January 1, 2008]

SDF-1 (CXCL12) in haematopoiesis and leukaemia: impact of DPP IV/CD26
Martin Hildebrandt, Richard Schabat
[Frontiers in Bioscience 13, 1774-1779, January 1, 2008]

DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetes
Carolyn F Deacon, Richard D Carr, Jens J Holst
[Frontiers in Bioscience 13, 1780-1794, January 1, 2008]

CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation
Timothy B. Campbell, Hal E. Broxmeyer
[Frontiers in Bioscience 13, 1795-1805, January 1, 2008]

Role of CD26/dipeptidyl peptidase IV in human T cell activation and function
Kei Ohnuma, Nozomu Takahashi, Tadanori Yamochi, Osamu Hosono, Nam H. Dang, Chikao Morimoto
[Frontiers in Bioscience 13, 2299-2310, January 1, 2008]

Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors - good or evil?
Petr Busek, Jarmila Stremenova, Aleksi Sedo
[Frontiers in Bioscience 13, 2319-2326, January 1, 2008]

Roles of molecules involved in epithelial/mesenchymal transition during angiogenesis
Giulio Ghersi
[Frontiers in Bioscience 13, 2335-2355, January 1, 2008]

DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis
Dirk Reinhold, Ute Bank, Michael Tager, Siegfried Ansorge, Sabine Wrenger, Anja Thielitz, Uwe Lendeckel, Jurgen Faust, Klaus Neubert, Stefan Brocke
[Frontiers in Bioscience 13, 2356-2363, January 1, 2008]

The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases
Anja Thielitz, Siegfried Ansorge, Ute Bank, Michael Tager, Sabine Wrenger, Harald Gollnick, Dirk Reinhold
[Frontiers in Bioscience 13, 2364-2375, January 1, 2008]

Dipeptidyl peptidase IV (DPPIV), a candidate tumor suppressor gene in melanomas is silenced by promoter methylation
Carolyn McGuinness, Umadevi V. Wesley
[Frontiers in Bioscience 13, 2435-2443, January 1, 2008]

Fibroblast activation protein and chronic liver disease
Xin Maggie Wang, Tsun-Wen Yao, Naveed A. Nadvi, Brenna Osborne, Geoffrey W. McCaughan, Mark D. Gorrell
[Frontiers in Bioscience 13, 3168-3180, January 1, 2008]

Non-substrate peptides influencing dipeptidyl peptidase IV/CD26 activity and immune cell function
Sabine Wrenger, Jurgen Faust, Carmen Mrestani-Klaus, Wolfgang Brandt, Anja Thielitz, Klaus Neubert, Dirk Reinhold
[Frontiers in Bioscience 13, 3194-3201, May 1, 2008]

Purification and characterization of dipeptidyl peptidase IV-like enzymes from bovine testes
Veronique Dubois, Anne-Marie Lambeir, Pieter Van der Veken, Koen Augustyns, John Creemers, Xin Chen, Simon Scharpe, Ingrid De Meester
[Frontiers in Bioscience 13, 3558-3568, May 1, 2008]

Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes
Peter R Flatt, Clifford J Bailey, Brian D Green
[Frontiers in Bioscience 13, 3648-3660, May 1, 2008]

Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors
Ute Bank, Ulrich R.M Bohr, Dirk Reinhold, Uwe Lendeckel, Siegfried Ansorge, Peter Malfertheiner, Michael Tager
[Frontiers in Bioscience 13, 3699-3713, May 1, 2008]